Cargando…
Oliceridine and its potential to revolutionize GI endoscopy sedation
Providing sedation to patients undergoing gastrointestinal (GI) endoscopy is a controversial and emotive issue. The mainstay of sedation is propofol, whose administration is within the sole jurisdiction of anesthesia providers, at least in the USA. Attempts have been made to seize the authority by t...
Autores principales: | Goudra, Basavana, Singh, Preet Mohinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458022/ https://www.ncbi.nlm.nih.gov/pubmed/32934628 http://dx.doi.org/10.4103/sja.SJA_813_19 |
Ejemplares similares
-
Anesthesia for GI endoscopy in the era of COVID-19
por: Goudra, Basavana, et al.
Publicado: (2021) -
Critical Analysis of Guidelines for Providing Sedation to Patients Undergoing Gastrointestinal Endoscopy Procedures
por: Goudra, Basavana, et al.
Publicado: (2019) -
Recent Developments in Devices Used for Gastrointestinal Endoscopy Sedation
por: Goudra, Basavana, et al.
Publicado: (2021) -
Remimazolam: The future of its sedative potential
por: Goudra, Basavana Gouda, et al.
Publicado: (2014) -
Oliceridine- Opioid of the 21(st) Century
por: Goudra, Basavana
Publicado: (2022)